CD4 and tuberculosis: Patients with CD4 <50 cells/mm3 or significantly advanced disease are prescribed to start ART within 2 weeks of starting anti-TB treatment, while those with an improved immunological profile (CD4 >50 cells/mm3) start ART two to 8 weeks after anti-TB treatment initiation.